Gene delivery | EPFL Graph Search

Êtes-vous un étudiant de l'EPFL à la recherche d'un projet de semestre?

Travaillez avec nous sur des projets en science des données et en visualisation, et déployez votre projet sous forme d'application sur GraphSearch.

Découvrez-en plus sur les applications Graph.

Gene delivery is the process of introducing foreign genetic material, such as DNA or RNA, into host cells. Gene delivery must reach the genome of the host cell to induce gene expression. Successful gene delivery requires the foreign gene delivery to remain stable within the host cell and can either integrate into the genome or replicate independently of it. This requires foreign DNA to be synthesized as part of a vector, which is designed to enter the desired host cell and deliver the transgene to that cell's genome. Vectors utilized as the method for gene delivery can be divided into two categories, recombinant viruses and synthetic vectors (viral and non-viral). In complex multicellular eukaryotes (more specifically Weissmanists), if the transgene is incorporated into the host's germline cells, the resulting host cell can pass the transgene to its progeny. If the transgene is incorporated into somatic cells, the transgene will stay with the somatic cell line, and thus its host organism. Gene delivery is a necessary step in gene therapy for the introduction or silencing of a gene to promote a therapeutic outcome in patients and also has applications in the genetic modification of crops. There are many different methods of gene delivery for various types of cells and tissues. Viral based vectors emerged in the 1980s as a tool for transgene expression. In 1983, Albert Siegel described the use of viral vectors in plant transgene expression although viral manipulation via cDNA cloning was not yet available. The first virus to be used as a vaccine vector was the vaccinia virus in 1984 as a way to protect chimpanzees against hepatitis B. Non-viral gene delivery was first reported on in 1943 by Avery et al. who showed cellular phenotype change via exogenous DNA exposure. There are a variety of methods available to deliver genes to host cells. When genes are delivered to bacteria or plants the process is called transformation and when it is used to deliver genes to animals it is called transfection.

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Publications associées (37)

Personnes associées (17)

Unités associées (1)

Concepts associés (10)

Cours associés (4)

Séances de cours associées (34)

MOOCs associés (6)

BIOENG-518: Methods: from disease models to therapy

This course will describe methods underlying translational approaches from disease modeling and characterization to therapeutic applications. The presented techniques will be complemented by hands-on

BIO-480: Neuroscience: from molecular mechanisms to disease

The goal of the course is to guide students through the essential aspects of molecular neuroscience and neurodegenerative diseases. The student will gain the ability to dissect the molecular basis of

BIOENG-320: Synthetic biology

This advanced Bachelor/Master level course will cover fundamentals and approaches at the interface of biology, chemistry, engineering and computer science for diverse fields of synthetic biology. This

Neuroscience Reconstructed: Genetics and Brain Development

This course will provide the fundamental knowledge in neuroscience required to understand how the brain is organised and how function at multiple scales is integrated to give rise to cognition and beh

Vecteurs non viraux

Explore l'utilisation de vecteurs non viraux pour la distribution précise d'acides nucléiques et leurs limites dans la réalisation de l'expression génique à long terme.

Thérapie génique: Maladies neurologiques

Explore la thérapie génique pour les maladies neurologiques, y compris les troubles monogéniques et multifactoriels, et l'utilisation de Cas9 et les mécanismes de réparation.

Obésité et mutations génétiques: impacts sur la régulation du poids

Explore les mutations génétiques affectant la régulation du poids et l'expression des gènes chez la souris.

Core-shell Structured Chitosan-polyethylenimine Nanoparticles for Gene Delivery: Improved Stability, Cellular Uptake, and Transfection Efficiency

Sandrine Gerber, Perrine Agnes Edith Robin, Laura Camille Louise Nicolle

Gene therapy emerged as a promising treatment option for acquired and inherited diseases. The delivery of nucleic acids relies on vectors that condense and encapsulate their cargo. Especially non-vira

2022

Engineering of chitosan-based derivatives for non-viral gene delivery

Laura Camille Louise Nicolle

Gene therapy offers the possibility to treat or even cure diseases originating from genetic defects by introducing a therapeutic gene in target cells or correcting the initial defective gene. Amongst

EPFL2022

Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions

Lilia Salimova

Amniotic fluid stem cells (AFSC) represent an attractive potential cell source for fetal and pediatric cell-based therapies. However, upgrading them to pluripotency confers refractoriness toward senes

Taylor & Francis Inc2016

Un ARN interférent est un acide ribonucléique (ARN) simple ou double brin dont l'interférence avec un ARN messager spécifique conduit à sa dégradation et à la diminution de sa traduction en protéine. Dans la mesure où l'ARN joue un rôle crucial dans l'expression des gènes, l'ARN interférent permet de bloquer celle-ci en rendant « silencieux » tel ou tel gène. Ce phénomène a été découvert dans les années 1990, valant à Andrew Z. Fire et Craig C. Mello le prix Nobel de physiologie et de médecine en 2006.

Un transgène est la séquence isolée d'un gène, transférée d'un organisme à un autre, lors de la mise en œuvre de la transgenèse. Cette modification peut altérer le comportement génétique de l'organisme (p. ex. production d'une nouvelle protéine). En agronomie, on parle de gène d’intérêt permettant de faire exprimer à un organisme un caractère choisi ; par exemple, on peut chercher à rendre une plante résistante à un antibiotique ou à augmenter sa teneur en vitamines.